Interview: experiences targeting B cells for the treatment of multiple sclerosis.
Genentech, Inc., 1 DNA Way, MS 34, South San Francisco, CA 94080, USA. acc@gene.com.
Andrew
A
Chan
Albert Jan
AJ
Schutte
Jonathan
J
Wilkinson
D001402:B-Lymphocytes / Q000276:immunology*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007167:Immunotherapy; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*